New Medicine to Make People Younger
New Medicine to Make People Younger
讓人類年輕的新藥
Introduction
David Sinclair is a scientist from Harvard. He wants to test a new pill on people. He thinks this pill can make people feel and look younger.
David Sinclair 是一位來自哈佛大學的科學家。他想在人類身上測試一種新藥，他認為這種藥物能讓人的感受與外貌變得更年輕。
Main Body
The pill is called SL-100. It tries to change how the body works. It wants to make the brain, muscles, and immune system strong again. This is like how a baby's body grows.
這種藥物被稱為 SL-100。它試圖改變身體的運作方式，旨在讓大腦、肌肉和免疫系統重新變得強壯。這就像嬰兒身體成長的過程。
A group called XPrize is helping with money. The scientists must show that people are ten years younger after one year. This will help scientists learn how to measure age.
一個名為 XPrize 的組織正提供資金協助。科學家必須證明，受試者在一年後能變得年輕十歲。這將有助於科學家學習如何衡量年齡。
Some other scientists are not sure. They say this kind of medicine can be dangerous. They also say David Sinclair did not have enough proof in old tests with dogs.
其他一些科學家則持有懷疑態度。他們表示這類藥物可能很危險，並指出 David Sinclair 在先前對狗進行的測試中缺乏足夠的證據。
Conclusion
We do not know if the pill works yet. The winners of the competition will be announced in August.
我們目前還不知道這種藥是否有效。競賽的獲勝者將於八月公布。
Vocabulary Learning
The 'Want' Pattern
In the story, we see this a lot:
- He wants to test a new pill.
- It wants to make the brain strong.
How it works:
When you have a wish or a goal, use:
PERSON + wants to + ACTION I want to learn English.
Word Shift: Comparing Age
Notice these two words:
- Younger (More young)
- Old (Not young)
When we compare two things (like a person now vs. a person 10 years ago), we add -er to the end of the short word.
Young Younger
Simple Facts (Present Tense)
Look at how the text gives information:
- David Sinclair is a scientist.
- The pill is called SL-100.
To describe someone or something, just use is (for one person/thing) or are (for many).
Vocabulary Learning
Human Clinical Trials Begin for Age-Reversal Drug Taken by Mouth
口服逆齡藥物開始進行人體臨床試驗
Introduction
Harvard biologist David Sinclair plans to start human trials for a chemical agent designed to reverse aging. This project is part of the XPrize Healthspan Competition, which aims to find ways to restore youth to the human body.
哈佛生物學家 David Sinclair 計劃針對一種旨在逆轉衰老的化學藥劑開始人體試驗。此項目是 XPrize Healthspan 競賽的一部分，目標是找出恢復人體年輕的方法。
Main Body
The treatment uses a process called epigenetic reprogramming. This method is based on the discovery of genes that can turn adult cells back into an early embryonic state. While Sinclair's company, Life Biosciences, previously worked on local gene therapy for eye problems, the new goal is to use a systemic oral drug called SL-100. This drug aims to reset DNA controls throughout the entire body, which could improve immune system, brain, and muscle functions.
這種治療使用的是一種稱為「表觀遺傳重編程」的過程。此方法基於發現了能將成年細胞恢復到早期胚胎狀態的基因。雖然 Sinclair 的公司 Life Biosciences 先前從事針對眼睛問題的局部基因治療，但新目標是使用一種名為 SL-100 的全身性口服藥物。該藥物旨在重設全身的 DNA 控制，進而改善免疫系統、大腦和肌肉功能。
This project is supported by the XPrize Foundation and funded by the Hevolution Foundation of Saudi Arabia. To win the competition, teams must prove that participants' biological age improved by ten years or more over one year. Consequently, this initiative helps create standard ways to measure aging, as scientists currently disagree on how to accurately measure age reversal.
此項目由 XPrize 基金會支持，並由沙烏地阿拉伯的 Hevolution 基金會資助。若要贏得競賽，團隊必須證明參與者的生物年齡在一年內改善了十年或更多。因此，這項計劃有助於建立衡量衰老的標準方法，因為科學家目前對於如何準確衡量逆轉衰老仍存在分歧。
However, some experts are skeptical of this method. For example, researcher Vadim Gladyshev stated that previous attempts to rejuvenate whole animals either had no effect at low doses or were poisonous at high doses. Furthermore, Sinclair's reputation has been questioned after he left the Academy for Health and Lifespan Research due to claims that he lacked enough evidence regarding a supplement tested on dogs. Despite these doubts, the field continues to attract huge investments, such as the $435 million raised by the startup NewLimit.
然而，部分專家對此方法持懷疑態度。例如，研究員 Vadim Gladyshev 指出，先前嘗試讓整個動物回春的嘗試，在低劑量下沒有效果，而高劑量下則有毒。此外，Sinclair 在離開健康與壽命研究學院後，因被指對一種在狗身上測試的補充劑缺乏足夠證據，其聲譽受到質疑。儘管存在這些質疑，該領域仍持續吸引巨額投資，例如初創公司 NewLimit 籌集了 4.35 億美元。
Conclusion
The effectiveness of the SL-100 drug has not yet been proven, and the final candidates for the competition will be announced in August.
SL-100 藥物的有效性尚未得到證明，競賽的最終入圍名單將於 8 月公布。
Vocabulary Learning
⚡ The 'Logic Connector' Shift
At an A2 level, you likely use and, but, and because. To reach B2, you need to use Cohesive Devices to show the relationship between two complex ideas. Let's look at how this article moves from simple storytelling to academic argument.
🧩 From 'But' to 'However' & 'Despite'
In the text, we see a shift in tone. Instead of saying "But some people don't believe it," the author uses:
*"However, some experts are skeptical..."
The B2 Upgrade: Use However at the start of a sentence followed by a comma to introduce a contrasting point. It signals to the reader that a 'pivot' is happening.
🔗 The Cause-and-Effect Chain
Look at this sequence:
Goal (Win competition) Action (Prove age improvement) Result (Create standard measures)
The text uses "Consequently" to bridge these ideas.
- A2 style: They want to win, so they make a way to measure age.
- B2 style: They aim to win the competition; consequently, this initiative helps create standard ways to measure aging.
🧪 Vocabulary Expansion: 'State' vs. 'Condition'
Notice the phrase "early embryonic state." In B2 English, we move away from general words like 'thing' or 'way'.
| A2 Word | B2 Alternative (from text) | Why it's better |
|---|---|---|
| Change | Reprogramming | More precise/technical |
| Doubt | Skeptical | Describes a mindset, not just a feeling |
| Whole | Systemic | Describes how something affects the entire system |
Pro Tip: When you see a word like 'systemic' or 'reprogramming', don't just translate it. Ask yourself: 'Does this describe a general action or a specific process?' That is the key to B2 precision.
Vocabulary Learning
Initiation of Human Clinical Trials for Systemic Epigenetic Reprogramming via Oral Administration
口服全身表觀遺傳重編程人體臨床試驗啟動
Introduction
Harvard biologist David Sinclair intends to conduct human trials of a chemical reprogramming agent to evaluate its capacity for age restoration within the framework of the XPrize Healthspan Competition.
哈佛生物學家 David Sinclair 打算在 XPrize 健康壽命競賽（XPrize Healthspan Competition）的框架下，對一種化學重編程藥劑進行人體試驗，以評估其恢復年齡的能力。
Main Body
The proposed intervention leverages the mechanism of epigenetic reprogramming, a process derived from the discovery of genes capable of reverting adult cells to a pluripotent embryonic state. While previous efforts by Sinclair's entity, Life Biosciences, focused on localized gene therapy for ocular conditions, the current objective involves the administration of a systemic oral compound, designated SL-100. This chemical approach seeks to mimic embryonic gene activity to reset molecular DNA controls across the entire organism, thereby enhancing immune, cognitive, and muscular functions.
此項建議的干預措施利用表觀遺傳重編程機制，該過程源於發現能將成年細胞還原至多能胚胎狀態的基因。雖然 Sinclair 創立的 Life Biosciences 先前專注於治療眼科疾病的局部基因療法，但目前的目標是使用一種名為 SL-100 的全身性口服化合物。這種化學方法旨在模仿胚胎基因活性，以重設整個生物體內的分子 DNA 控制，從而增強免疫、認知和肌肉功能。
Institutional support for this endeavor is provided by the XPrize Foundation, with funding from the Hevolution Foundation of Saudi Arabia. The competition mandates that participating teams demonstrate a relative age improvement of ten years or more over a twelve-month period. Consequently, the initiative serves as a catalyst for the establishment of standardized metrics for aging, addressing a critical lack of consensus within the scientific community regarding the measurement of age reversal.
此次嘗試由 XPrize 基金會提供制度支持，並由沙烏地阿拉伯的 Hevolution 基金會資助。比賽要求參賽團隊在 12 個月內證明相對年齡改善 10 年或以上。因此，該計劃成為建立標準化衰老指標的催化劑，解決了科學界在衡量年齡逆轉方面嚴重缺乏共識的問題。
Despite the stated objectives, the methodology remains subject to academic scrutiny. External researchers, including Vadim Gladyshev, have reported that previous attempts at whole-animal chemical rejuvenation resulted in either negligible effects at low dosages or systemic toxicity at higher concentrations. Furthermore, the professional standing of Sinclair has been contested following his resignation from the Academy for Health and Lifespan Research, precipitated by allegations of insufficient evidence regarding the efficacy of a supplement in canine subjects. Nevertheless, the pursuit of systemic rejuvenation continues to attract substantial capital, as evidenced by the $435 million funding secured by the startup NewLimit for organ-specific reprogramming.
儘管有上述目標，但該方法仍受到學術審查。包括 Vadim Gladyshev 在內的外部研究人員報告指出，先前嘗試對全動物進行化學回春，結果在低劑量下效果微乎其微，而在高濃度時則導致全身性中毒。此外，Sinclair 在從健康與壽命研究學院（Academy for Health and Lifespan Research）辭職後，其專業地位受到質疑，而辭職原因是被指控缺乏關於某種補劑對犬類受試者有效的證據。儘管如此，對全身回春的追求仍吸引大量資金，例如初創公司 NewLimit 為器官特異性重編程籌集了 4.35 億美元。
Conclusion
The efficacy of the SL-100 compound remains unverified, with final competition candidates to be announced in August.
SL-100 化合物的功效仍未經證實，最終的比賽候選名單將於 8 月公布。
Vocabulary Learning
The Architecture of 'Academic Distancing' & Nominalization
To transition from B2 to C2, a student must move beyond describing an event to framing it. The provided text is a masterclass in Epistemic Hedging and High-Density Nominalization, the linguistic hallmarks of scholarly English.
◈ The Nominalization Engine
Notice how the text avoids verbs of action in favor of noun phrases. This shifts the focus from the person doing the act to the concept itself.
- B2 approach: "The team wants to standardize how we measure aging because scientists don't agree." (Action-oriented/Simple)
- C2 approach: "...the initiative serves as a catalyst for the establishment of standardized metrics for aging, addressing a critical lack of consensus..."
Analysis: By turning "standardize" (verb) into "establishment of standardized metrics" (noun phrase), the author creates a static, objective atmosphere. The "lack of consensus" becomes a tangible entity rather than a disagreement between people.
◈ Precision in Veridicality (The Art of the Hedge)
C2 mastery requires the ability to report controversial information without sounding biased. Observe the transition from clinical ambition to professional skepticism:
*"...precipitated by allegations of insufficient evidence..."
Linguistic Breakdown:
- "Precipitated by": A high-level alternative to "caused by," suggesting a chemical-like trigger or a sudden collapse.
- "Allegations of": This is the critical 'shield.' It prevents the author from stating the failure as a fact, attributing it instead to a claim.
- "Insufficient evidence": A precise, cold academic phrase that replaces "it didn't work."
◈ Lexical Sophistication: The 'Systemic' Thread
Throughout the text, the word "systemic" is used with surgical precision. It does not merely mean "general"; it refers to the entire biological system (systemic oral compound, systemic toxicity, systemic rejuvenation).
C2 Takeaway: Use adjectives that carry technical weight to eliminate ambiguity. Replace general terms (wide-spread, total, overall) with domain-specific modifiers (systemic, holistic, comprehensive) to signal professional authority.